These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16467596)

  • 1. Edaravone diminishes free radicals from circulating neutrophils in patients with ischemic brain attack.
    Aizawa H; Makita Y; Sumitomo K; Aburakawa Y; Katayama T; Nakatani-Enomoto S; Suzuki Y; Fujiwara K; Enomoto H; Kuroda K; Kimura T; Yahara O; Koyama S; Maruyama J; Nakamura M; Hasebe N; Kikuchi K
    Intern Med; 2006; 45(1):1-4. PubMed ID: 16467596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Research and development of the free radical scavenger edaravone as a neuroprotectant].
    Watanabe T; Tanaka M; Watanabe K; Takamatsu Y; Tobe A
    Yakugaku Zasshi; 2004 Mar; 124(3):99-111. PubMed ID: 15049127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo.
    Inokuchi Y; Imai S; Nakajima Y; Shimazawa M; Aihara M; Araie M; Hara H
    J Pharmacol Exp Ther; 2009 May; 329(2):687-98. PubMed ID: 19201991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Edaravone (radical scavenger) versus sodium ozagrel (antiplatelet agent) in acute noncardioembolic ischemic stroke (EDO trial).
    Shinohara Y; Saito I; Kobayashi S; Uchiyama S
    Cerebrovasc Dis; 2009; 27(5):485-92. PubMed ID: 19321945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Edaravone in acute ischemic stroke.
    Kitagawa Y
    Intern Med; 2006; 45(5):225-6. PubMed ID: 16595983
    [No Abstract]   [Full Text] [Related]  

  • 6. The synergetic effect of edaravone and borneol in the rat model of ischemic stroke.
    Wu HY; Tang Y; Gao LY; Sun WX; Hua Y; Yang SB; Zhang ZP; Liao GY; Zhou QG; Luo CX; Zhu DY
    Eur J Pharmacol; 2014 Oct; 740():522-31. PubMed ID: 24975100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute kidney injury and edaravone in acute ischemic stroke: the Fukuoka Stroke Registry.
    Kamouchi M; Sakai H; Kiyohara Y; Minematsu K; Hayashi K; Kitazono T
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e470-6. PubMed ID: 23800495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Edaravone, a free radical scavenger, attenuates behavioral deficits following transient forebrain ischemia by inhibiting oxidative damage in gerbils.
    Lu F; Nakamura T; Toyoshima T; Liu Y; Hirooka K; Kawai N; Okabe N; Shiraga F; Tamiya T; Miyamoto O; Keep RF; Itano T
    Neurosci Lett; 2012 Jan; 506(1):28-32. PubMed ID: 22040669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a novel free radical scavenger, for treatment of cardiovascular diseases.
    Higashi Y; Jitsuiki D; Chayama K; Yoshizumi M
    Recent Pat Cardiovasc Drug Discov; 2006 Jan; 1(1):85-93. PubMed ID: 18221078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of edaravone, a free radical scavenger, on serum levels of inflammatory biomarkers in acute brain infarction.
    Isahaya K; Yamada K; Yamatoku M; Sakurai K; Takaishi S; Kato B; Hirayama T; Hasegawa Y
    J Stroke Cerebrovasc Dis; 2012 Feb; 21(2):102-7. PubMed ID: 21215657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of edaravone, a free radical scavenger, on ischemic cerebral edema assessed by magnetic resonance imaging.
    Suda S; Igarashi H; Arai Y; Andou J; Chishiki T; Katayama Y
    Neurol Med Chir (Tokyo); 2007 May; 47(5):197-201; discussion 201-2. PubMed ID: 17527045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease.
    Kikuchi K; Tancharoen S; Takeshige N; Yoshitomi M; Morioka M; Murai Y; Tanaka E
    Int J Mol Sci; 2013 Jul; 14(7):13909-30. PubMed ID: 23880849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological and clinical profile of the free radical scavenger edaravone as a neuroprotective agent].
    Tanaka M
    Nihon Yakurigaku Zasshi; 2002 May; 119(5):301-8. PubMed ID: 12061142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Edaravone attenuates oxidative stress induced by chronic cerebral hypoperfusion injury: role of ERK/Nrf2/HO-1 signaling pathway.
    Zhang D; Xiao Y; Lv P; Teng Z; Dong Y; Qi Q; Liu Z
    Neurol Res; 2018 Jan; 40(1):1-10. PubMed ID: 29125058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney.
    Doi K; Suzuki Y; Nakao A; Fujita T; Noiri E
    Kidney Int; 2004 May; 65(5):1714-23. PubMed ID: 15086910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of edaravone on singlet oxygen released from activated human neutrophils.
    Sommani P; Arai T; Yamashita K; Miyoshi T; Mori H; Sasada M; Makino K
    J Pharmacol Sci; 2007 Jan; 103(1):117-20. PubMed ID: 17202745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent free radical scavenger, edaravone, suppresses oxidative stress-induced endothelial damage and early atherosclerosis.
    Xi H; Akishita M; Nagai K; Yu W; Hasegawa H; Eto M; Kozaki K; Toba K
    Atherosclerosis; 2007 Apr; 191(2):281-9. PubMed ID: 16806227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Edaravone for the treatment of acute cerebral infarction: role of endothelium-derived nitric oxide and oxidative stress.
    Higashi Y
    Expert Opin Pharmacother; 2009 Feb; 10(2):323-31. PubMed ID: 19236202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of edaravone on the estimated glomerular filtration rate in patients with acute ischemic stroke and chronic kidney disease.
    Tsukamoto Y; Takizawa S; Takahashi W; Mase H; Miyachi H; Miyata T; Takagi S
    J Stroke Cerebrovasc Dis; 2011; 20(2):111-6. PubMed ID: 20580255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antioxidant edaravone prevents cardiac dysfunction by suppressing oxidative stress in type 1 diabetic rats and in high-glucose-induced injured H9c2 cardiomyoblasts.
    Ji L; Liu Y; Zhang Y; Chang W; Gong J; Wei S; Li X; Qin L
    Can J Physiol Pharmacol; 2016 Sep; 94(9):996-1006. PubMed ID: 27376621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.